Logistics & Transportation

Articles

The company’s Mourenx plant in Southwest France aims to become an API network hub, with first supplies expected by next year. 

Axplora Invests $52.5 Million into GLP-1 Manufacturing Facility

Videos

In the fourth part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Jenna Dale, director of client relations at Cencora, explains the value of FDA guidance documents for manufacturers, along with the areas of CGT development that would benefit most from standardization.

Building Confidence in CGT Innovation

The facilities are expected to offer pharma shipment support by addressing time and temperature-specific requirements. 

UPS Welcomes Three New Cross-Dock Plants

In the second part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Jenna Dale, director of client relations at Cencora, explains the challenges associated with meeting the FDA’s 2025 CGT forecasted approval goal. 

Tackling Gaps in Manufacturing, Funding, and Expertise

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Alex Guillen, global pharma and life sciences director at Tive, shares how the development of technology will help bolster the pharma logistics industry. 

The Future of Personalized Medicine

A founding partner with Curatio Scientia Advisors.

A founding partner with Curatio Scientia Advisor.

A report offers a comprehensive benchmarking and assessment of pharmaceutical manufacturer engagement with specialty pharmacies.

Transforming Specialty Pharmacy Engagement

In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Alex Guillen, global pharma and life sciences director at Tive, explains what needs to be done in the United States in order to increase manufacturing output.

Strengthening Production Efforts Domestically 

In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Alex Guillen, global pharma and life sciences director at Tive, describes the highlights of a recent pharma supply chain security and visibility report that his company released.

Analyzing Supply Chain Complexities 

The 7,000 square-foot GMP facility will provide formulation development support, along with analytical testing services. 

Upperton Pharma Solutions Finalizes Construction of Sterile Manufacturing Plant

The license agreement will feature an upcoming Phase III trial and—depending on results—the development, manufacturing, and commercialization of evenamide as a potential treatment option.

Manufacturing & Packaging